Patent · US Active

Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators

US10570139B2 · kind B2 · utility

22Cited by
7References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 3, 2018
Grant dateFeb 25, 2020
Priority date—
Expiry dateMay 3, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is fused heterocyclic compounds of formula (I), and salts thereof, compositions thereof, and methods of use therefor. In particular, disclosed herein are certain fused heterocyclic compounds that can be useful for inhibiting protein kinase, including Bruton's tyrosine kinase (Btk), and for treating disorders mediated thereby.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.